Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Meadow

JULY 13, 2018

19:05) What equity programs are currently in place in each of your cities and why are they important to you and your city? (25:28) 25:28) Going beyond equity programs, have there been conversations about creating more diversity in the cannabis industry in your respective cities?

Wellness and Beauty 40

Wellness and Beauty Policy Consumption Cannabis 40

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2003, 2004, 2007, 2008, Nov. Preventing marijuana possession or use on federal property. . 101–189, div.

Banking 45

Banking Law Marijuana State Laws 45